Dennis B Leeper

Title: Dennis B. Leeper: Innovator in Stem Cell Therapy

Introduction

Dennis B. Leeper is a notable inventor based in Wynnewood, Pennsylvania. He holds two prestigious patents that contribute significantly to the field of regenerative medicine, particularly focusing on isolated stromal cells and their therapeutic applications.

Latest Patents

One of Leeper's latest patents involves isolated stromal cells and methods for treating patients suffering from diseases, disorders, or conditions characterized by bone, cartilage, or lung defects. The disclosed methods include the intravenous administration of stromal cells isolated from normal syngeneic individuals. Additionally, his patent describes the administration of stromal cells isolated from patients after correcting genetic defects within those cells.

Another significant patent revolves around implant devices that house stromal cells isolated from bone marrow, including a gene construct. This construct encodes beneficial proteins linked to regulatory elements functioning within the stromal cells. Leeper's work highlights innovative methods for treating individuals with genetic disorders, emphasizing the introduction of transfected adherent cells into the patient's system while protecting them from the recipient's immune response.

Career Highlights

Leeper is affiliated with Thomas Jefferson University, where his research focuses on advanced therapeutic strategies employing isolated stromal cells. His patents reflect a commitment to finding solutions for conditions that currently have limited treatment options.

Collaborations

Throughout his career, Leeper has collaborated with renowned scientists such as Darwin J. Prockop and Ruth F. Pereira. Their combined expertise in regenerative medicine has led to significant advancements and innovations in the understanding and application of stromal cell therapies.

Conclusion

Dennis B. Leeper's contributions to stem cell research and regenerative medicine underscore the critical role of innovation in developing novel treatments. His patents demonstrate the potential of stromal cell therapies for addressing various severe medical conditions, marking him as a prominent figure in the field.